A Putative New Growth Factor in Ascitic Fluid from Ovarian Cancer Patients: Identification, Characterization, and Mechanism of Action

Cancer Research

Volumn 48, Issue 5, 1988, Pages 1066-1071

  Mills, Gordon B ^a   May, Christopher ^a   McGill, Martha ^a   Roifman, Chaim M ^b   Mellors, Alan ^c  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR;

ASCITES FLUID; CLINICAL ARTICLE; FEMALE; HUMAN; OVARY CANCER;

ASCITIC FLUID; CALCIUM; FEMALE; GROWTH SUBSTANCES; HUMAN; INOSITOL PHOSPHATES; OVARIAN NEOPLASMS; PEPTIDES; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTORS; TUMOR CELLS, CULTURED;

EID: 0023860289     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Varmus, H. E. The molecular genetics of cellular oncogenes. Annu. Rev. Genet., 18: 553–561, 1984.
2. Sporn M. B., and Roberts, A. B. Autocrine growth factors and cancer. Nature (Lond.), 313:745-747,1985.
3. Klein, G., and Klein, E. Evolution of tumours and the impact of molecular oncology. Nature (Lond.), 315:190-195, 1985.
4. Filmus, J. E., and Buick, R. N. Stability of c-K-ras amplification during progression in a patient with adenocarcinoma of the ovary. Cancer Res., 45: 4468–4472, 1985.
5. Krontiris, T. D. The emerging genetics of human cancer. New Engl. J. Med., 309:404-409, 1983.
6. Feig, L. A., Bast, R. C., Jr., Knapp, R. C., and Cooper, G. M. Somatic activation of rask gene in a human ovarian carcinoma. Science (Wash. DC), 223:689-701,1984.
7. Yokota, J., Tsunetsugu-Yohata, Battifora, H., LeFevre, C., and Cline, M. J. Alerations of myc, myb, and rasHa proto-oncogenes in cancer are frequent and show clinical correlation. Science (Wash. DC), 231: 261–265, 1985.
8. Buick, R. N., Pullano, R., and Trent, J. M. Comparative properties of five human ovarian carcinoma cell lines. Cancer Res., 45:3668-3676, 1985.
9. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260:3440-3446,1985.
10. Mills, G. B., Cheung, R. K., Grinstein, S., and Gelfand, E. W. Interleukin 2-induced lymphocyte proliferation is independent of increases in cytosolic-free calcium concentrations. J. Immunol., 134:2431-2435, 1985.
11. Mills, G. B., Stewart, D. J., Mellors, A., and Gelfand, E. W. Interleukin 2 does not induce phosphatidylinositol hydrolysis in activated T cells. J. Immunol., 136: 3019–3024, 1986.
12. Hamburger, A. W. The human tumor clonogenic assay as a model in cell biology. Int. J. Cell Cloning, 5; 89–107, 1987.
13. Mackillop, W. J., Ciampi, A., Till, J. E., and Buick, R. N. A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J. Natl. Cancer Inst., 70:9-16, 1983.
14. Moolenar, W. H., Defize, L. H. K., Van Der Saag, P. T., and De Laat, S. W. The generation of ionic signals by growth factors. Cur. Top. Membr. Transp., 26:137-156, 1986.
15. Majerus, P. W., Connolly, T. M., Deckmyn, H., Ross, T. S., Bross, T. E., Ishii, H., Bansal, V. S., and Wilson, D. B. The metabolism of phosphoino-sitide-derived messenger molecules. Science (Wash. DC), 234: 1519–1526, 1986.
16. Robb, R. J., Greene, W. C., and Rusk, C. M. Low and high affinity cellular receptors for interleukin 2. J. Exp. Med., 160:1126-1146, 1984.
17. Guilbert, L. J., Tynan, P. W., and Stanley, E. R. Uptake and destruction of,25I-CSF-1 by peritoneal exudate macrophages. J. Cell. Biol. 31: 203–216, 1986.
18. Hunt, J. W., and Eardley, D. D. Suppressive effects of insulin and insulin-like growth factor-1 (IgFl) on immune responses. J. Immunol., 136: 3994–3999, 1986.
19. Welander, C. R., Natale, R. B., and Lewis, J. R. In vitro growth stimulation of human ovarian cancer cells by xenogeneic peritoneal macrophages. J. Natl. Cancer Inst., 69:1035-1043, 1982.
20. Buick, R. N., Fry, S. E., and Salmon, S. E. Effect of host-cell interaction on clonogenic carcinoma cells in human malignant effusions. Br. J. Cancer, 41: 695-704,1980.
21. Peri, G., Zanaboni, F., Rossini, F., et al. Evaluation of the interaction of mononuclear phagocytes with ovarian cancer cells in a colony assay. Br. J. Cancer, 53:47-52, 1986.
22. Duram, S. K., Schmidt, J. A., and Oppenheim, J. J. Interleukin 1: an immunological perspective. Ann. Rev. Immunol., 3:263-287,1985.
23. Broxterman, H. J., Sprenkels-Schotte, C., Engelen P., Leyva, A., and Pinedo, H. M. Analysis of human ascites effect on clonogenic growth of human tumor cell lines and NRK-49F cells in soft agar. Int. J. Cell Cloning, 5:158-169,1987.
24. Sherwin, S. A., Twardzik, D. R., Bohn, W. H., Cockley, K. D., and Todaro, G. J. High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res., 43:403-407, 1983.
25. Nickell, K. A., and Moses, H. L. Transforming growth factor (TGF)-like substances in solid human malignant neoplasms. J. Cell. Biol., 92: 240A, 1981.
26. Uitendaal, M. P., Hubers, H. A., McVie, J. G., and Pinedo, H. M. Human tumor clonogenicity in agar is improved by cell free ascites. Br. J. Cancer, 48:55-59, 1983.